Press release from Companies
Publicerat: 2025-06-12 13:10:00
OSLO, NORWAY – 12 June 2025: Genetic Analysis AS ("GA" or "the Company") announces that members of the Board and Management have subscribed for shares in the ongoing share offering in GA.
Tore Grøttum, Interim CFO in Genetic Analysis AS, has today including oversubscription subscribed for 200.000 new GEAN-shares at a price of 0.86 NOK per share. Tore Grøttum will, following the transaction and provided that the oversubscribed shares are allocated, own 1,834,840 shares following the transaction.
For further information, please contact:
Ronny Hermansen, CEO
E-mail: rh@genetic-analysis.com
Tore Grøttum, Interim Chief Financial Officer
E-mail: tg@genetic-analysis.com
About Genetic Analysis:
Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 15 years of expertise in research and product development. The unique GA-map® platform is based on a pre-determined multiplex targets approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to help unlocking and restoring the human microbiome through its state-of-the-art technology. GA employs a team of highly qualified employees with scientific backgrounds and competence in sales, operations, bioinformatics, molecular biology, and bioengineering.
For more general information: www.genetic-analysis.com
Interested in reading more about GA's products? Please visit www.ga-map.com
Stay updated on GA and sign up for more investor-related information: https://www.genetic-analysis.com/subscriptions/
